The first patients with sickle cell disease (SCD) have been treated by NHS England with the “life-changing” drug, crizanlizumab (Adakveo; Novartis). Loury Mooruth, 62, who was among the earliest patients to receive the drug, said: “Whenever I thought about having this new drug it…
Impact of sickle cell disease on the Nigerian child
Sickle cell disease is a genetic multisystemic disorder characterised by chronic anaemia, episodes of acute and possible chronic pain, progressive organ failure and a possibility of reduced life expectancy. It is originally a blood disorder that is inherited from one’s…